Human genetics of infectious diseases: Unique insights into immunological redundancy

Seminars in Immunology

Volumn 36, Issue , 2018, Pages 1-12

  Casanova, Jean Laurent ^a,b,c,d   Abel, Laurent ^a,c,d  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Inborn error of immunity; Knockout; Loss of function; Natural selection; Primary infection; Redundancy

Indexed keywords

GENE DISRUPTION; HUMAN; HUMAN GENETICS; IMMUNITY; IMMUNOGENETICS; INFECTION; MIXED INFECTION; REVIEW; ASYMPTOMATIC DISEASE; COMMUNICABLE DISEASE; EVOLUTION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HOST PATHOGEN INTERACTION; IMMUNE DEFICIENCY; IMMUNOLOGY; PHENOTYPE; VIRAL TROPISM; X CHROMOSOME LINKED DISORDER;

ASYMPTOMATIC DISEASES; BIOLOGICAL EVOLUTION; COMMUNICABLE DISEASES; GENETIC DISEASES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IMMUNOLOGIC DEFICIENCY SYNDROMES; PHENOTYPE; VIRAL TROPISM;

EID: 85039455920     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2017.12.008     Document Type: Review

References (168)

1. Casadevall, A., Pirofski, L.A., What is a host Ii: the attributes of individual susceptibility. Infect. Immun., 2017.
2. Casanova, J.L., Human genetic basis of interindividual variability in the course of infection. Proc. Natl. Acad. Sci. U. S. A. 112:51 (2015), E7118–27.
3. Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C.J., Furman, D., Shen-Orr, S., Dekker, C.L., Swan, G.E., Butte, A.J., Maecker, H.T., Davis, M.M., Variation in the human immune system is largely driven by non-heritable influences. Cell 160:1-2 (2015), 37–47.
4. Casanova, J.L., Abel, L., Disentangling inborn and acquired immunity in human twins. Cell 160:1-2 (2015), 13–15.
5. Casanova, J.L., Abel, L., The genetic theory of infectious diseases: a brief history and selected illustrations. Annu. Rev. Genomics Hum. Genet. 14 (2013), 215–243.
6. Alcais, A., Quintana-Murci, L., Thaler, D.S., Schurr, E., Abel, L., Casanova, J.L., Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?. Ann. N. Y. Acad. Sci. 1214:1 (2010), 18–33.
7. Casanova, J.L., Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl. Acad. Sci. U. S. A. 112:51 (2015), E7128–37.
8. Casanova, J.L., Abel, L., Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202:2 (2005), 197–201.
9. Pasteur, L., Etudes sur la maladie des vers à soie. La pébrine et la flacherie. 1 ed., 1870, Gauthiers-Villars.
10. Etzioni, A., Ochs, H., Primary Immunodeficiency Disorders. A Historic and Scientific Perspective. 2014, Academic Press.
11. Zhang, Y., Su, H.C., Lenardo, M.J., Genomics is rapidly advancing precision medicine for immunological disorders. Nat. Immunol. 16:10 (2015), 1001–1004.
12. Bousfiha, A., Jeddane, L., Al-Herz, W., Ailal, F., Casanova, J.L., Chatila, T., Conley, M.E., Cunningham-Rundles, C., Etzioni, A., Franco, J.L., Gaspar, H.B., Holland, S.M., Klein, C., Nonoyama, S., Ochs, H.D., Oksenhendler, E., Picard, C., Puck, J.M., Sullivan, K.E., Tang, M.L., The 2015 IUIS phenotypic classification for primary immunodeficiencies. J. Clin. Immunol. 35:8 (2015), 727–738.
13. Picard, C., Al-Herz, W., Bousfiha, A., Casanova, J.L., Chatila, T., Conley, M.E., Cunningham-Rundles, C., Etzioni, A., Holland, S.M., Klein, C., Nonoyama, S., Ochs, H.D., Oksenhendler, E., Puck, J.M., Sullivan, K.E., Tang, M.L., Franco, J.L., Gaspar, H.B., Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J. Clin. Immunol. 35:8 (2015), 696–726.
14. Deschamps, M., Laval, G., Fagny, M., Itan, Y., Abel, L., Casanova, J.L., Patin, E., Quintana-Murci, L., Genomic signatures of selective pressures and introgression from archaic hominins at human innate immunity genes. Am. J. Hum. Genet. 98:1 (2016), 5–21.
15. Fischer, A., Rausell, A., Primary immunodeficiencies suggest redundancy within the human immune system. Sci. Immunol., 1(6), 2016.
16. Li, J., Barreda, D.R., Zhang, Y.A., Boshra, H., Gelman, A.E., Lapatra, S., Tort, L., Sunyer, J.O., B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities. Nat. Immunol. 7:10 (2006), 1116–1124.
17. Alkuraya, F.S., Human knockout research: new horizons and opportunities. Trends Genet. 31:2 (2015), 108–115.
18. Casanova, J.L., Abel, L., Quintana-Murci, L., Immunology taught by human genetics. Cold Spring Harb. Symp. Quant. Biol. 78 (2013), 157–172.
19. Casanova, J.L., Abel, L., The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4:1 (2004), 55–66.
20. Quintana-Murci, L., Alcais, A., Abel, L., Casanova, J.L., Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8:11 (2007), 1165–1171.
21. Bonthron, D.T., Markham, A.F., Ginsburg, D., Orkin, S.H., Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency. J. Clin. Invest. 76:2 (1985), 894–897.
22. Picard, C., Casanova, J.L., Abel, L., Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 18:4 (2006), 383–390.
23. Narasimhan, V.M., Xue, Y., Tyler-Smith, C., Human knockout carriers: dead, diseased, healthy, or improved?. Trends Mol. Med. 22:4 (2016), 341–351.
24. Lim, E.T., Wurtz, P., Havulinna, A.S., Palta, P., Tukiainen, T., Rehnstrom, K., Esko, T., Magi, R., Inouye, M., Lappalainen, T., Chan, Y., Salem, R.M., Lek, M., Flannick, J., Sim, X., Manning, A., Ladenvall, C., Bumpstead, S., Hamalainen, E., Aalto, K., Maksimow, M., Salmi, M., Blankenberg, S., Ardissino, D., Shah, S., Horne, B., McPherson, R., Hovingh, G.K., Reilly, M.P., Watkins, H., Goel, A., Farrall, M., Girelli, D., Reiner, A.P., Stitziel, N.O., Kathiresan, S., Gabriel, S., Barrett, J.C., Lehtimaki, T., Laakso, M., Groop, L., Kaprio, J., Perola, M., McCarthy, M.I., Boehnke, M., Altshuler, D.M., Lindgren, C.M., Hirschhorn, J.N., Metspalu, A., Freimer, N.B., Zeller, T., Jalkanen, S., Koskinen, S., Raitakari, O., Durbin, R., MacArthur, D.G., Salomaa, V., Ripatti, S., Daly, M.J., Palotie, A., Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet., 10(7), 2014, e1004494.
25. Sulem, P., Helgason, H., Oddson, A., Stefansson, H., Gudjonsson, S.A., Zink, F., Hjartarson, E., Sigurdsson, G.T., Jonasdottir, A., Sigurdsson, A., Magnusson, O.T., Kong, A., Helgason, A., Holm, H., Thorsteinsdottir, U., Masson, G., Gudbjartsson, D.F., Stefansson, K., Identification of a large set of rare complete human knockouts. Nat. Genet. 47:5 (2015), 448–452.
26. Narasimhan, V.M., Hunt, K.A., Mason, D., Baker, C.L., Karczewski, K.J., Barnes, M.R., Barnett, A.H., Bates, C., Bellary, S., Bockett, N.A., Giorda, K., Griffiths, C.J., Hemingway, H., Jia, Z., Kelly, M.A., Khawaja, H.A., Lek, M., McCarthy, S., McEachan, R., O'Donnell-Luria, A., Paigen, K., Parisinos, C.A., Sheridan, E., Southgate, L., Tee, L., Thomas, M., Xue, Y., Schnall-Levin, M., Petkov, P.M., Tyler-Smith, C., Maher, E.R., Trembath, R.C., MacArthur, D.G., Wright, J., Durbin, R., van Heel, D.A., Health and population effects of rare gene knockouts in adult humans with related parents. Science 352:6284 (2016), 474–477.
27. Saleheen, D., Natarajan, P., Armean, I.M., Zhao, W., Rasheed, A., Khetarpal, S.A., Won, H.H., Karczewski, K.J., O'Donnell-Luria, A.H., Samocha, K.E., Weisburd, B., Gupta, N., Zaidi, M., Samuel, M., Imran, A., Abbas, S., Majeed, F., Ishaq, M., Akhtar, S., Trindade, K., Mucksavage, M., Qamar, N., Zaman, K.S., Yaqoob, Z., Saghir, T., Rizvi, S.N.H., Memon, A., Hayyat Mallick, N., Rasheed, S.Z., Memon, F.U., Mahmood, K., Ahmed, N., Do, R., Krauss, R.M., MacArthur, D.G., Gabriel, S., Lander, E.S., Daly, M.J., Frossard, P., Danesh, J., Rader, D.J., Kathiresan, S., Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature 544:7649 (2017), 235–239.
28. Lek, M., Karczewski, K.J., Minikel, E.V., Samocha, K.E., Banks, E., Fennell, T., O'Donnell-Luria, A.H., Ware, J.S., Hill, A.J., Cummings, B.B., Tukiainen, T., Birnbaum, D.P., Kosmicki, J.A., Duncan, L.E., Estrada, K., Zhao, F., Zou, J., Pierce-Hoffman, E., Berghout, J., Cooper, D.N., Deflaux, N., DePristo, M., Do, R., Flannick, J., Fromer, M., Gauthier, L., Goldstein, J., Gupta, N., Howrigan, D., Kiezun, A., Kurki, M.I., Moonshine, A.L., Natarajan, P., Orozco, L., Peloso, G.M., Poplin, R., Rivas, M.A., Ruano-Rubio, V., Rose, S.A., Ruderfer, D.M., Shakir, K., Stenson, P.D., Stevens, C., Thomas, B.P., Tiao, G., Tusie-Luna, M.T., Weisburd, B., Won, H.H., Yu, D., Altshuler, D.M., Ardissino, D., Boehnke, M., Danesh, J., Donnelly, S., Elosua, R., Florez, J.C., Gabriel, S.B., Getz, G., Glatt, S.J., Hultman, C.M., Kathiresan, S., Laakso, M., McCarroll, S., McCarthy, M.I., McGovern, D., McPherson, R., Neale, B.M., Palotie, A., Purcell, S.M., Saleheen, D., Scharf, J.M., Sklar, P., Sullivan, P.F., Tuomilehto, J., Tsuang, M.T., Watkins, H.C., Wilson, J.G., Daly, M.J., MacArthur, D.G., Analysis of protein-coding genetic variation in 60, 706 humans. Nature 536:7616 (2016), 285–291.
29. Gineau, L., Cognet, C., Kara, N., Lach, F.P., Dunne, J., Veturi, U., Picard, C., Trouillet, C., Eidenschenk, C., Aoufouchi, S., Alcais, A., Smith, O., Geissmann, F., Feighery, C., Abel, L., Smogorzewska, A., Stillman, B., Vivier, E., Casanova, J.L., Jouanguy, E., Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J. Clin. Invest. 122:3 (2012), 821–832.
30. Cottineau, J., Kottemann, M.C., Lach, F.P., Kang, Y.H., Vely, F., Deenick, E.K., Lazarov, T., Gineau, L., Wang, Y., Farina, A., Chansel, M., Lorenzo, L., Piperoglou, C., Ma, C.S., Nitschke, P., Belkadi, A., Itan, Y., Boisson, B., Jabot-Hanin, F., Picard, C., Bustamante, J., Eidenschenk, C., Boucherit, S., Aladjidi, N., Lacombe, D., Barat, P., Qasim, W., Hurst, J.A., Pollard, A.J., Uhlig, H.H., Fieschi, C., Michon, J., Bermudez, V.P., Abel, L., de Villartay, J.P., Geissmann, F., Tangye, S.G., Hurwitz, J., Vivier, E., Casanova, J.L., Smogorzewska, A., Jouanguy, E., Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J. Clin. Invest. 127:5 (2017), 1991–2006.
31. Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., Metin, A., Karasuyama, H., Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448:7157 (2007), 1058–1062.
32. Hahn, C.N., Chong, C.E., Carmichael, C.L., Wilkins, E.J., Brautigan, P.J., Li, X.C., Babic, M., Lin, M., Carmagnac, A., Lee, Y.K., Kok, C.H., Gagliardi, L., Friend, K.L., Ekert, P.G., Butcher, C.M., Brown, A.L., Lewis, I.D., To, L.B., Timms, A.E., Storek, J., Moore, S., Altree, M., Escher, R., Bardy, P.G., Suthers, G.K., D'Andrea, R.J., Horwitz, M.S., Scott, H.S., Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43:10 (2011), 1012–1017.
33. Hsu, A.P., Sampaio, E.P., Khan, J., Calvo, K.R., Lemieux, J.E., Patel, S.Y., Frucht, D.M., Vinh, D.C., Auth, R.D., Freeman, A.F., Olivier, K.N., Uzel, G., Zerbe, C.S., Spalding, C., Pittaluga, S., Raffeld, M., Kuhns, D.B., Ding, L., Paulson, M.L., Marciano, B.E., Gea-Banacloche, J.C., Orange, J.S., Cuellar-Rodriguez, J., Hickstein, D.D., Holland, S.M., Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118:10 (2011), 2653–2655.
34. Ostergaard, P., Simpson, M.A., Connell, F.C., Steward, C.G., Brice, G., Woollard, W.J., Dafou, D., Kilo, T., Smithson, S., Lunt, P., Murday, V.A., Hodgson, S., Keenan, R., Pilz, D.T., Martinez-Corral, I., Makinen, T., Mortimer, P.S., Jeffery, S., Trembath, R.C., Mansour, S., Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 43:10 (2011), 929–931.
35. Dickinson, R.E., Griffin, H., Bigley, V., Reynard, L.N., Hussain, R., Haniffa, M., Lakey, J.H., Rahman, T., Wang, X.N., McGovern, N., Pagan, S., Cookson, S., McDonald, D., Chua, I., Wallis, J., Cant, A., Wright, M., Keavney, B., Chinnery, P.F., Loughlin, J., Hambleton, S., Santibanez-Koref, M., Collin, M., Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118:10 (2011), 2656–2658.
36. Itan, Y., Casanova, J.L., Can the impact of human genetic variations be predicted?. Proc. Natl. Acad. Sci. U. S. A. 112:37 (2015), 11426–11427.
37. Miosge, L.A., Field, M.A., Sontani, Y., Cho, V., Johnson, S., Palkova, A., Balakishnan, B., Liang, R., Zhang, Y., Lyon, S., Beutler, B., Whittle, B., Bertram, E.M., Enders, A., Goodnow, C.C., Andrews, T.D., Comparison of predicted and actual consequences of missense mutations. Proc. Natl. Acad. Sci. U. S. A. 112:37 (2015), E5189–98.
38. Kircher, M., Witten, D.M., Jain, P., O'Roak, B.J., Cooper, G.M., Shendure, J., A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46:3 (2014), 310–315.
39. Itan, Y., Shang, L., Boisson, B., Ciancanelli, M.J., Markle, J.G., Martinez-Barricarte, R., Scott, E., Shah, I., Stenson, P.D., Gleeson, J., Cooper, D.N., Quintana-Murci, L., Zhang, S.Y., Abel, L., Casanova, J.L., The mutation significance cutoff: gene-level thresholds for variant predictions. Nat. Methods 13:2 (2016), 109–110.
40. Conley, M.E., Dobbs, A.K., Farmer, D.M., Kilic, S., Paris, K., Grigoriadou, S., Coustan-Smith, E., Howard, V., Campana, D., Primary B cell immunodeficiencies: comparisons and contrasts. Annu. Rev. Immunol. 27 (2009), 199–227.
41. Buckley, R.H., Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22 (2004), 625–655.
42. Klein, C., Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu. Rev. Immunol. 29 (2011), 399–413.
43. Conley, M.E., B cells in patients with X-linked agammaglobulinemia. J. Immunol. 134:5 (1985), 3070–3074.
44. Bruton, O.C., Agammaglobulinemia. Pediatrics 9 (1952), 722–728.
45. Bruton, O.C., A decade with agammaglobulinemia. J. Pediatr. 60 (1962), 672–676.
46. Tsukada, S., Saffran, D.C., Rawlings, D.J., Parolini, O., Allen, R.C., Klisak, I., Sparkes, R.S., Kubagawa, H., Mohandas, T., Quan, S., et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:2 (1993), 279–290.
47. Conley, M.E., Dobbs, A.K., Quintana, A.M., Bosompem, A., Wang, Y.D., Coustan-Smith, E., Smith, A.M., Perez, E.E., Murray, P.J., Agammaglobulinemia and absent B lineage cells in a patient lacking the p85alpha subunit of PI3K. J. Exp. Med. 209:3 (2012), 463–470.
48. Schwarz, K., Gauss, G.H., Ludwig, L., Pannicke, U., Li, Z., Lindner, D., Friedrich, W., Seger, R.A., Hansen-Hagge, T.E., Desiderio, S., Lieber, M.R., Bartram, C.R., RAG mutations in human B cell-negative SCID. Science 274:5284 (1996), 97–99.
49. Notarangelo, L.D., Kim, M.S., Walter, J.E., Lee, Y.N., Human RAG mutations: biochemistry and clinical implications. Nat. Rev. Immunol. 16:4 (2016), 234–246.
50. Morgan, N.V., Goddard, S., Cardno, T.S., McDonald, D., Rahman, F., Barge, D., Ciupek, A., Straatman-Iwanowska, A., Pasha, S., Guckian, M., Anderson, G., Huissoon, A., Cant, A., Tate, W.P., Hambleton, S., Maher, E.R., Mutation in the TCRalpha subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of TCRalphabeta+ T cells. J. Clin. Invest. 121:2 (2011), 695–702.
51. Hirano, M., Guo, P., McCurley, N., Schorpp, M., Das, S., Boehm, T., Cooper, M.D., Evolutionary implications of a third lymphocyte lineage in lampreys. Nature 501:7467 (2013), 435–438.
52. Kostmann, R., Hereditär reticulos − en ny systemsjukdom. Svenska Läkartdin, 47, 1950, 2861.
53. Kostmann, R., Infantile genetic agranulocytosis. Acta Pediatr. Scand. 45 (1956), 1–78.
54. Kostmann, R., Infantile genetic agranulocytosis: a review with presentation of ten new cases. Acta Pediatr. Scand. 64 (1975), 362–368.
55. Ishikawa, N., Okada, S., Miki, M., Shirao, K., Kihara, H., Tsumura, M., Nakamura, K., Kawaguchi, H., Ohtsubo, M., Yasunaga, S., Matsubara, K., Sako, M., Hara, J., Shiohara, M., Kojima, S., Sato, T., Takihara, Y., Kobayashi, M., Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J. Med. Genet. 45:12 (2008), 802–807.
56. Germeshausen, M., Grudzien, M., Zeidler, C., Abdollahpour, H., Yetgin, S., Rezaei, N., Ballmaier, M., Grimbacher, B., Welte, K., Klein, C., Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 111:10 (2008), 4954–4957.
57. Hambleton, S., Salem, S., Bustamante, J., Bigley, V., Boisson-Dupuis, S., Azevedo, J., Fortin, A., Haniffa, M., Ceron-Gutierrez, L., Bacon, C.M., Menon, G., Trouillet, C., McDonald, D., Carey, P., Ginhoux, F., Alsina, L., Zumwalt, T.J., Kong, X.F., Kumararatne, D., Butler, K., Hubeau, M., Feinberg, J., Al-Muhsen, S., Cant, A., Abel, L., Chaussabel, D., Doffinger, R., Talesnik, E., Grumach, A., Duarte, A., Abarca, K., Moraes-Vasconcelos, D., Burk, D., Berghuis, A., Geissmann, F., Collin, M., Casanova, J.L., Gros, P., IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365:2 (2011), 127–138.
58. Mahlaoui, N., Minard-Colin, V., Picard, C., Bolze, A., Ku, C.L., Tournilhac, O., Gilbert-Dussardier, B., Pautard, B., Durand, P., Devictor, D., Lachassinne, E., Guillois, B., Morin, M., Gouraud, F., Valensi, F., Fischer, A., Puel, A., Abel, L., Bonnet, D., Casanova, J.L., Isolated congenital asplenia: a French nationwide retrospective survey of 20 cases. J. Pediatr. 158:1 (2011), 142–148 (148 e1).
59. Biesma, D.H., Hannema, A.J., van Velzen-Blad, H., Mulder, L., van Zwieten, R., Kluijt, I., Roos, D., A family with complement factor D deficiency. J. Clin. Invest. 108:2 (2001), 233–240.
60. Harriman, G.R., Esser, A.F., Podack, E.R., Wunderlich, A.C., Braude, A.I., Lint, T.F., Curd, J.G., The role of C9 in complement-mediated killing of Neisseria. J. Immunol. 127:6 (1981), 2386–2390.
61. Lee, T.J., Utsinger, P.D., Snyderman, R., Yount, W.J., Sparling, P.F., Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria. J. Infect. Dis. 138:3 (1978), 359–368.
62. Lim, D., Gewurz, A., Lint, T.F., Ghaze, M., Sepheri, B., Gewurz, H., Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J. Pediatr. 89:1 (1976), 42–47.
63. Nagata, M., Hara, T., Aoki, T., Mizuno, Y., Akeda, H., Inaba, S., Tsumoto, K., Ueda, K., Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis. J. Pediatr. 114:2 (1989), 260–264.
64. Nielsen, H.E., Christensen, K.C., Koch, C., Thomsen, B.S., Heegaard, N.H., Tranum-Jensen, J., Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease. Scand. J. Immunol. 30:6 (1989), 711–718.
65. Petersen, B.H., Graham, J.A., Brooks, G.F., Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity. J. Clin. Invest. 57:2 (1976), 283–290.
66. Sjoholm, A.G., Braconier, J.H., Soderstrom, C., Properdin deficiency in a family with fulminant meningococcal infections. Clin. Exp. Immunol. 50:2 (1982), 291–297.
67. Vanhamme, L., Paturiaux-Hanocq, F., Poelvoorde, P., Nolan, D.P., Lins, L., Van Den Abbeele, J., Pays, A., Tebabi, P., Van Xong, H., Jacquet, A., Moguilevsky, N., Dieu, M., Kane, J.P., De Baetselier, P., Brasseur, R., Pays, E., Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422:6927 (2003), 83–87.
68. Vanhollebeke, B., Truc, P., Poelvoorde, P., Pays, A., Joshi, P.P., Katti, R., Jannin, J.G., Pays, E., Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. N. Engl. J. Med. 355:26 (2006), 2752–2756.
69. Newport, M.J., Huxley, C.M., Huston, S., Hawrylowicz, C.M., Oostra, B.A., Williamson, R., Levin, M., A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:26 (1996), 1941–1949.
70. Jouanguy, E., Altare, F., Lamhamedi, S., Revy, P., Emile, J.F., Newport, M., Levin, M., Blanche, S., Seboun, E., Fischer, A., Casanova, J.L., Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:26 (1996), 1956–1961.
71. Bustamante, J., Boisson-Dupuis, S., Abel, L., Casanova, J.L., Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin. Immunol. 114:2 (1989), 454–470.
72. Puel, A., Cypowyj, S., Bustamante, J., Wright, J.F., Liu, L., Lim, H.K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., Gumbleton, M., Toulon, A., Bodemer, C., El-Baghdadi, J., Whitters, M., Paradis, T., Brooks, J., Collins, M., Wolfman, N.M., Al-Muhsen, S., Galicchio, M., Abel, L., Picard, C., Casanova, J.L., Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332:6025 (2011), 65–68.
73. Ling, Y., Cypowyj, S., Aytekin, C., Galicchio, M., Camcioglu, Y., Nepesov, S., Ikinciogullari, A., Dogu, F., Belkadi, A., Levy, R., Migaud, M., Boisson, B., Bolze, A., Itan, Y., Goudin, N., Cottineau, J., Picard, C., Abel, L., Bustamante, J., Casanova, J.L., A. Puel, Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J. Exp. Med. 212:5 (2015), 619–631.
74. Levy, R., Okada, S., Beziat, V., Moriya, K., Liu, C., Chai, L.Y., Migaud, M., Hauck, F., Al Ali, A., Cyrus, C., Vatte, C., Patiroglu, T., Unal, E., Ferneiny, M., Hyakuna, N., Nepesov, S., Oleastro, M., Ikinciogullari, A., Dogu, F., Asano, T., Ohara, O., Yun, L., Della Mina, E., Bronnimann, D., Itan, Y., Gothe, F., Bustamante, J., Boisson-Dupuis, S., Tahuil, N., Aytekin, C., Salhi, A., Al Muhsen, S., Kobayashi, M., Toubiana, J., Abel, L., Li, X., Camcioglu, Y., Celmeli, F., Klein, C., AlKhater, S.A., Casanova, J.L., Puel, A., Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc. Natl. Acad. Sci. U. S. A. 113:51 (2016), E8277–E8285.
75. Lanternier, F., Pathan, S., Vincent, Q.B., Liu, L., Cypowyj, S., Prando, C., Migaud, M., Taibi, L., Ammar-Khodja, A., Boudghene Stambouli, O., Guellil, B., Jacobs, F., Goffard, J.C., Schepers, K., del Marmol, V., Boussofara, L., Denguezli, M., Larif, M., Bachelez, H., Michel, L., Lefranc, G., Hay, R., Jouvion, G., Chretien, F., Fraitag, S., Bougnoux, M.E., Boudia, M., Abel, L., Lortholary, O., Casanova, J.L., Picard, C., Grimbacher, B., Puel, A., Deep dermatophytosis and inherited CARD9 deficiency. N. Engl. J. Med. 369:18 (2013), 1704–1714.
76. Glocker, E.O., Hennigs, A., Nabavi, M., Schaffer, A.A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., Jamal, S., Manguiat, A., Rezaei, N., Amirzargar, A.A., Plebani, A., Hannesschlager, N., Gross, O., Ruland, J., Grimbacher, B., A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361:18 (2009), 1727–1735.
77. Palendira, U., Low, C., Bell, A.I., Ma, C.S., Abbott, R.J., Phan, T.G., Riminton, D.S., Choo, S., Smart, J.M., Lougaris, V., Giliani, S., Buckley, R.H., Grimbacher, B., Alvaro, F., Klion, A.D., Nichols, K.E., Adelstein, S., Rickinson, A.B., Tangye, S.G., Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. J. Exp. Med. 209:5 (2012), 913–924.
78. Palendira, U., Low, C., Chan, A., Hislop, A.D., Ho, E., Phan, T.G., Deenick, E., Cook, M.C., Riminton, D.S., Choo, S., Loh, R., Alvaro, F., Booth, C., Gaspar, H.B., Moretta, A., Khanna, R., Rickinson, A.B., Tangye, S.G., Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol., 9(11), 2011, e1001187.
79. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M.G., Oettgen, H., De Vries, J.E., Aversall, G., Terhorst, C., The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395 (1998), 462–469.
80. Nichols, K.E., Harkin, D.P., Levitz, S., Krainer, M., Kolquist, K.A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A.J., Wise, C., Ashley, J., Lovett, M., Valentine, M.B., Look, A.T., Gerald, W., Housman, D.E., Haber, D.A., Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. U. S. A. 95:23 (1998), 13765–13770.
81. Coffey, A.J., Brooksbank, R.A., Brandau, O., Oohashi, T., Howell, G.R., Bye, J.M., Cahn, A.P., Durham, J., Heath, P., Wray, P., Pavitt, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, C.J., Dunham, A., Rhodes, S., Schuster, V., Porta, G., Yin, L., Serafini, P., Sylla, B., Zollo, M., Franco, B., Bolino, A., Seri, M., Lanyi, A., Davis, J.R., Webster, D., Harris, A., Lenoir, G., de St Basile, G., Jones, A., Behloradsky, B.H., Achatz, H., Murken, J., Fassler, R., Sumegi, J., Romeo, G., Vaudin, M., Ross, M.T., Meindl, A., Bentley, D.R., Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20 (1998), 129–135.
82. Tangye, S.G., Palendira, U., Edwards, E.S., Human immunity against EBV-lessons from the clinic. J. Exp. Med. 214:2 (2017), 269–283.
83. Li, F.Y., Chaigne-Delalande, B., Kanellopoulou, C., Davis, J.C., Matthews, H.F., Douek, D.C., Cohen, J.I., Uzel, G., Su, H.C., Lenardo, M.J., Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475:7357 (2011), 471–476.
84. Abolhassani, H., Edwards, E.S., Ikinciogullari, A., Jing, H., Borte, S., Buggert, M., Du, L., Matsuda-Lennikov, M., Romano, R., Caridha, R., Bade, S., Zhang, Y., Frederiksen, J., Fang, M., Bal, S.K., Haskologlu, S., Dogu, F., Tacyildiz, N., Matthews, H.F., McElwee, J.J., Gostick, E., Price, D.A., Palendira, U., Aghamohammadi, A., Boisson, B., Rezaei, N., Karlsson, A.C., Lenardo, M.J., Casanova, J.L., Hammarstrom, L., Tangye, S.G., Su, H.C., Pan-Hammarstrom, Q., Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J. Exp. Med. 214:1 (2017), 91–106.
85. Izawa, K., Martin, E., Soudais, C., Bruneau, J., Boutboul, D., Rodriguez, R., Lenoir, C., Hislop, A.D., Besson, C., Touzot, F., Picard, C., Callebaut, I., de Villartay, J.P., Moshous, D., Fischer, A., Latour, S., Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J. Exp. Med. 214:1 (2017), 73–89.
86. Orth, G., Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr. Top. Microbiol. Immunol. 321 (2008), 59–83.
87. Ramoz, N., Rueda, L.A., Bouadjar, B., Montoya, L.S., Orth, G., Favre, M., Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32:4 (2002), 579–581.
88. Crequer, A., Picard, C., Pedergnana, V., Lim, A., Zhang, S.Y., Abel, L., Majewski, S., Casanova, J.L., Jablonska, S., Orth, G., Jouanguy, E., EVER2 deficiency is associated with mild T-cell abnormalities. J. Clin. Immunol. 33:1 (2013), 14–21.
89. O'Shea, J.J., Paul, W.E., Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:5969 (2010), 1098–1102.
90. Sallusto, F., Heterogeneity of human CD4(+) t cells against microbes. Annu. Rev. Immunol. 34 (2016), 317–334.
91. Altare, F., Ensser, A., Breiman, A., Reichenbach, J., Baghdadi, J.E., Fischer, A., Emile, J.F., Gaillard, J.L., Meinl, E., Casanova, J.L., Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J. Infect. Dis. 184:2 (2001), 231–236.
92. Boisson-Dupuis, S., El Baghdadi, J., Parvaneh, N., Bousfiha, A., Bustamante, J., Feinberg, J., Samarina, A., Grant, A.V., Janniere, L., El Hafidi, N., Hassani, A., Nolan, D., Najib, J., Camcioglu, Y., Hatipoglu, N., Aydogmus, C., Tanir, G., Aytekin, C., Keser, M., Somer, A., Aksu, G., Kutukculer, N., Mansouri, D., Mahdaviani, A., Mamishi, S., Alcais, A., Abel, L., Casanova, J.L., IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One, 6(4), 2011, e18524.
93. Caragol, I., Raspall, M., Fieschi, C., Feinberg, J., Larrosa, M.N., Hernandez, M., Figueras, C., Bertran, J.M., Casanova, J.L., Espanol, T., Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin. Infect. Dis. 37:2 (2003), 302–306.
94. Ozbek, N., Fieschi, C., Yilmaz, B.T., de Beaucoudrey, L., Demirhan, B., Feinberg, J., Bikmaz, Y.E., Casanova, J.L., Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis. Clin. Infect. Dis. 40:6 (2005), e55–8.
95. Tabarsi, P., Marjani, M., Mansouri, N., Farnia, P., Boisson-Dupuis, S., Bustamante, J., Abel, L., Adimi, P., Casanova, J.L., Mansouri, D., Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency. J. Clin. Immunol. 31:4 (2011), 537–539.
96. Picard, C., Puel, A., Bonnet, M., Ku, C.L., Bustamante, J., Yang, K., Soudais, C., Dupuis, S., Feinberg, J., Fieschi, C., Elbim, C., Hitchcock, R., Lammas, D., Davies, G., Al-Ghonaium, A., Al-Rayes, H., Al-Jumaah, S., Al-Hajjar, S., Al-Mohsen, I.Z., Frayha, H.H., Rucker, R., Hawn, T.R., Aderem, A., Tufenkeji, H., Haraguchi, S., Day, N.K., Good, R.A., Gougerot-Pocidalo, M.A., Ozinsky, A., Casanova, J.L., Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299:5615 (2003), 2076–2079.
97. von Bernuth, H., Picard, C., Jin, Z., Pankla, R., Xiao, H., Ku, C.L., Chrabieh, M., Mustapha, I.B., Ghandil, P., Camcioglu, Y., Vasconcelos, J., Sirvent, N., Guedes, M., Vitor, A.B., Herrero-Mata, M.J., Arostegui, J.I., Rodrigo, C., Alsina, L., Ruiz-Ortiz, E., Juan, M., Fortuny, C., Yague, J., Anton, J., Pascal, M., Chang, H.H., Janniere, L., Rose, Y., Garty, B.Z., Chapel, H., Issekutz, A., Marodi, L., Rodriguez-Gallego, C., Banchereau, J., Abel, L., Li, X., Chaussabel, D., Puel, A., Casanova, J.L., Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:5889 (2008), 691–696.
98. Casanova, J.L., Abel, L., Quintana-Murci, L., Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29 (2011), 447–491.
99. Zhang, S.Y., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P., Segal, D., Sancho-Shimizu, V., Lorenzo, L., Puel, A., Picard, C., Chapgier, A., Plancoulaine, S., Titeux, M., Cognet, C., von Bernuth, H., Ku, C.L., Casrouge, A., Zhang, X.X., Barreiro, L., Leonard, J., Hamilton, C., Lebon, P., Heron, B.L., Vallee Quintana-Murci, L.A., Hovnanian, F., Rozenberg, E., Vivier, F., Geissmann, M., Tardieu, L., Abel, J.L., Casanova, TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:5844 (2007), 1522–1527.
100. Lafaille, F.G., Pessach, I.M., Zhang, S.Y., Ciancanelli, M.J., Herman, M., Abhyankar, A., Ying, S.W., Keros, S., Goldstein, P.A., Mostoslavsky, G., Ordovas-Montanes, J., Jouanguy, E., Plancoulaine, S., Tu, E., Elkabetz, Y., Al-Muhsen, S., Tardieu, M., Schlaeger, T.M., Daley, G.Q., Abel, L., Casanova, J.L., Studer, L., Notarangelo, L.D., Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491:7426 (2012), 769–773.
101. Casrouge, A., Zhang, S.Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., Alcais, A., Picard, C., Mahfoufi, N., Nicolas, N., Lorenzo, L., Plancoulaine, S., Senechal, B., Geissmann, F., Tabeta, K., Hoebe, K., Du, X., Miller, R.L., Heron, B., Mignot, C., de Villemeur, T.B., Lebon, P., Dulac, O., Rozenberg, F., Beutler, B., Tardieu, M., Abel, L., Casanova, J.L., Herpes simplex virus encephalitis in human UNC-93 B deficiency. Science 314:5797 (2006), 308–312.
102. Byun, M., Ma, C.S., Akcay, A., Pedergnana, V., Palendira, U., Myoung, J., Avery, D.T., Liu, Y., Abhyankar, A., Lorenzo, L., Schmidt, M., Lim, H.K., Cassar, O., Migaud, M., Rozenberg, F., Canpolat, N., Aydogan, G., Fleckenstein, B., Bustamante, J., Picard, C., Gessain, A., Jouanguy, E., Cesarman, E., Olivier, M., Gros, P., Abel, L., Croft, M., Tangye, S.G., Casanova, J.L., Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J. Exp. Med. 210:9 (2013), 1743–1759.
103. Ciancanelli, M.J., Huang, S.X., Luthra, P., Garner, H., Itan, Y., Volpi, S., Lafaille, F.G., Trouillet, C., Schmolke, M., Albrecht, R.A., Israelsson, E., Lim, H.K., Casadio, M., Hermesh, T., Lorenzo, L., Leung, L.W., Pedergnana, V., Boisson, B., Okada, S., Picard, C., Ringuier, B., Troussier, F., Chaussabel, D., Abel, L., Pellier, I., Notarangelo, L.D., Garcia-Sastre, A., Basler, C.F., Geissmann, F., Zhang, S.Y., Snoeck, H.W., Casanova, J.L., Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348:6233 (2015), 448–453.
104. Lamborn, I.T., Jing, H., Zhang, Y., Drutman, S.B., Abbott, J.K., Munir, S., Bade, S., Murdock, H.M., Santos, C.P., Brock, L.G., Masutani, E., Fordjour, E.Y., McElwee, J.J., Hughes, J.D., Nichols, D.P., Belkadi, A., Oler, A.J., Happel, C.S., Matthews, H.F., Abel, L., Collins, P.L., Subbarao, K., Gelfand, E.W., Ciancanelli, M.J., Casanova, J.L., Su, H.C., Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J. Exp. Med. 214:7 (2017), 1949–1972.
105. Ogunjimi, B., Zhang, S.Y., Sorensen, K.B., Skipper, K.A., Carter-Timofte, M., Kerner, G., Luecke, S., Prabakaran, T., Cai, Y., Meester, J., Bartholomeus, E., Bolar, N.A., Vandeweyer, G., Claes, C., Sillis, Y., Lorenzo, L., Fiorenza, R.A., Boucherit, S., Dielman, C., Heynderickx, S., Elias, G., Kurotova, A., Auwera, A.V., Verstraete, L., Lagae, L., Verhelst, H., Jansen, A., Ramet, J., Suls, A., Smits, E., Ceulemans, B., Van Laer, L., Plat Wilson, G., Kreth, J., Picard, C., Von Bernuth, H., Fluss, J., Chabrier, S., Abel, L., Mortier, G., Fribourg, S., Mikkelsen, J.G., Casanova, J.L., Paludan, S.R., Mogensen, T.H., Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J. Clin. Invest. 127:9 (2017), 3543–3556.
106. Israel, L., Wang, Y., Bulek, K., Della Mina, E., Zhang, Z., Pedergnana, V., Chrabieh, M., Lemmens, N.A., Sancho-Shimizu, V., Descatoire, M., Lasseau, T., Israelsson, E., Lorenzo, L., Yun, L., Belkadi, A., Moran, A., Weisman, L.E., Vandenesch, F., Batteux, F., Weller, S., Levin, M., Herberg, J., Abhyankar, A., Prando, C., Itan, Y., van Wamel, W.J., Picard, C., Abel, L., Chaussabel, D., Li, X., Beutler, B., Arkwright, P.D., Casanova, J.L., Puel, A., Human adaptive immunity rescues an inborn error of innate immunity. Cell 168:5 (2017), 789–800 (e10).
107. Manry, J., Laval, G., Patin, E., Fornarino, S., Itan, Y., Fumagalli, M., Sironi, M., Tichit, M., Bouchier, C., Casanova, J.L., Barreiro, L.B., Quintana-Murci, L., Evolutionary genetic dissection of human interferons. J. Exp. Med. 208:13 (2011), 2747–2759.
108. Hawn, T.R., Verbon, A., Lettinga, K.D., Zhao, L.P., Li, S.S., Laws, R.J., Skerrett, S.J., Beutler, B., Schroeder, L., Nachman, A., Ozinsky, A., Smith, K.D., Aderem, A., A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198:10 (2003), 1563–1572.
109. Merx, S., Zimmer, W., Neumaier, M., Ahmad-Nejad, P., Characterization and functional investigation of single nucleotide polymorphisms (SNPs) in the human TLR5 gene. Hum. Mutat., 27(3), 2006, 293.
110. Quach, H., Wilson, D., Laval, G., Patin, E., Manry, J., Guibert, J., Barreiro, L.B., Nerrienet, E., Verschoor, E., Gessain, A., Przeworski, M., Quintana-Murci, L., Different selective pressures shape the evolution of Toll-like receptors in human and African great ape populations. Hum. Mol. Genet. 22:23 (2013), 4829–4840.
111. Zhao, Y., Shao, F., The NAIP-NLRC4 inflammasome in innate immune detection of bacterial flagellin and type III secretion apparatus. Immunol. Rev. 265:1 (2015), 85–102.
112. Zhao, Y., Yang, J., Shi, J., Gong, Y.N., Lu, Q., Xu, H., Liu, L., Shao, F., The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:7366 (2011), 596–600.
113. Ferwerda, B., Ferwerda, G., Plantinga, T.S., Willment, J.A., van Spriel, A.B., Venselaar, H., Elbers, C.C., Johnson, M.D., Cambi, A., Huysamen, C., Jacobs, L., Jansen, T., Verheijen, K., Masthoff, L., Morre, S.A., Vriend, G., Williams, D.L., Perfect, J.R., Joosten, L.A., Wijmenga, C., van der Meer, J.W., Adema, G.J., Kullberg, B.J., Brown, G.D., Netea, M.G., Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361:18 (2009), 1760–1767.
114. Puel, A., Cypowyj, S., Marodi, L., Abel, L., Picard, C., Casanova, J.L., Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr. Opin. Allergy Clin. Immunol. 12:6 (2012), 616–622.
115. Fujita, T., Matsushita, M., Endo, Y., The lectin-complement pathway–its role in innate immunity and evolution. Immunol. Rev. 198 (2004), 185–202.
116. Casanova, J.L., Abel, L., Human mannose-binding lectin in immunity: friend, foe, or both?. J. Exp. Med. 199:10 (2004), 1295–1299.
117. Lundbo, L.F., Sorensen, H.T., Clausen, L.N., Hollegaard, M.V., Hougaard, D.M., Konradsen, H.B., Harboe, Z.B., Norgaard, M., Benfield, T., Mannose-binding lectin gene, MBL2, polymorphisms do not increase susceptibility to invasive meningococcal disease in a population of danish children. Open Forum Infect Dis., 2(4), 2015 (ofv127).
118. Keizer, M.P., Wouters, D., Schlapbach, L.J., Kuijpers, T.W., Restoration of MBL-deficiency: redefining the safety, efficacy and viability of MBL-substitution therapy. Mol. Immunol. 61:2 (2014), 174–184.
119. Verdu, P., Barreiro, L.B., Patin, E., Gessain, A., Cassar, O., Kidd, J.R., Kidd, K.K., Behar, D.M., Froment, A., Heyer, E., Sica, L., Casanova, J.L., Abel, L., Quintana-Murci, L., Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum. Mol. Genet. 15:17 (2006), 2650–2658.
120. Cabrera, A., Neculai, D., Kain, K.C., CD36 and malaria: friends or foes? A decade of data provides some answers. Trends Parasitol. 30:9 (2014), 436–444.
121. Aitman, T.J., Cooper, L.D., Norsworthy, P.J., Wahid, F.N., Gray, J.K., Curtis, B.R., McKeigue, P.M., Kwiatkowski, D., Greenwood, B.M., Snow, R.W., Hill, A.V., Scott, J., Malaria susceptibility and CD36 mutation. Nature 405:6790 (2000), 1015–1016.
122. Ayodo, G., Price, A.L., Keinan, A., Ajwang, A., Otieno, M.F., Orago, A.S., Patterson, N., Reich, D., Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants. Am. J. Hum. Genet. 81:2 (2007), 234–242.
123. Pain, A., Urban, B.C., Kai, O., Casals-Pascual, C., Shafi, J., Marsh, K., Roberts, D.J., A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357:9267 (2001), 1502–1503.
124. Sabeti, P.C., Schaffner, S.F., Fry, B., Lohmueller, J., Varilly, P., Shamovsky, O., Palma, A., Mikkelsen, T.S., Altshuler, D., Lander, E.S., Positive natural selection in the human lineage. Science 312:5780 (2006), 1614–1620.
125. Fry, A.E., Ghansa, A., Small, K.S., Palma, A., Auburn, S., Diakite, M., Green, A., Campino, S., Teo, Y.Y., Clark, T.G., Jeffreys, A.E., Wilson, J., Jallow, M., Sisay-Joof, F., Pinder, M., Griffiths, M.J., Peshu, N., Williams, T.N., Newton, C.R., Marsh, K., Molyneux, M.E., Taylor, T.E., Koram, K.A., Oduro, A.R., Rogers, W.O., Rockett, K.A., Sabeti, P.C., Kwiatkowski, D.P., Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum. Mol. Genet. 18:14 (2009), 2683–2692.
126. Allison, A.C., Genetic control of resistance to human malaria. Curr. Opin. Immunol. 21:5 (2009), 499–505.
127. Taylor, S.M., Parobek, C.M., Fairhurst, R.M., Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect. Dis. 12:6 (2012), 457–468.
128. Kwiatkowski, D.P., How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77:2 (2005), 171–192.
129. Modiano, D., Luoni, G., Sirima, B.S., Simpore, J., Verra, F., Konate, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G.M., D'Urbano, L., Sanou, I., Sawadogo, A., Modiano, G., Coluzzi, M., Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414:6861 (2001), 305–308.
130. Barreiro, L.B., Quintana-Murci, L., From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet. 11:1 (2010), 17–30.
131. Quintana-Murci, L., Clark, A.G., Population genetic tools for dissecting innate immunity in humans. Nat. Rev. Immunol. 13:4 (2013), 280–293.
132. Cohen, J.C., Boerwinkle, E., Mosley, T.H. Jr., Hobbs, H.H., Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354:12 (2006), 1264–1272.
133. Zhao, Z., Tuakli-Wosornu, Y., Lagace, T.A., Kinch, L., Grishin, N.V., Horton, J.D., Cohen, J.C., Hobbs, H.H., Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am. J. Hum. Genet. 79:3 (2006), 514–523.
134. Miller, L.H., Mason, S.J., Clyde, D.F., McGinniss, M.H., The resistance factor to Plasmodium vivax in blacks. The Duffy-blood- group genotype, FyFy. N. Engl. J. Med. 295:6 (1976), 302–304.
135. Tournamille, C., Colin, Y., Cartron, J.P., Le Van Kim, C., Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10:2 (1995), 224–228.
136. Howes, R.E., Patil, A.P., Piel, F.B., Nyangiri, O.A., Kabaria, C.W., Gething, P.W., Zimmerman, P.A., Barnadas, C., Beall, C.M., Gebremedhin, A., Menard, D., Williams, T.N., Weatherall, D.J., Hay, S.I., The global distribution of the Duffy blood group. Nat. Commun., 2, 2011, 266.
137. McManus, K.F., Taravella, A.M., Henn, B.M., Bustamante, C.D., Sikora, M., Cornejo, O.E., Population genetic analysis of the DARC locus (Duffy) reveals adaptation from standing variation associated with malaria resistance in humans. PLoS Genet., 13(3), 2017, e1006560.
138. Singh, S.K., Hora, R., Belrhali, H., Chitnis, C.E., Sharma, A., Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439:7077 (2006), 741–744.
139. Payne, R.O., Silk, S.E., Elias, S.C., Milne, K.H., Rawlinson, T.A., Llewellyn, D., Shakri, A.R., Jin, J., Labbe, G.M., Edwards, N.J., Poulton, I.D., Roberts, R., Farid, R., Jorgensen, T., Alanine, D.G., de Cassan, S.C., Higgins, M.K., Otto, T.D., McCarthy, J.S., de Jongh, W.A., Nicosia, A., Moyle, S., Hill, A.V., Berrie, E., Chitnis, C.E., Lawrie, A.M., Draper, S.J., Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies. JCI Insight, 2(12), 2017.
140. Grimberg, B.T., Udomsangpetch, R., Xainli, J., McHenry, A., Panichakul, T., Sattabongkot, J., Cui, L., Bockarie, M., Chitnis, C., Adams, J., Zimmerman, P.A., King, C.L., Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med., 4(12), 2007, e337.
141. King, C.L., Michon, P., Shakri, A.R., Marcotty, A., Stanisic, D., Zimmerman, P.A., Cole-Tobian, J.L., Mueller, I., Chitnis, C.E., Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. U. S. A. 105:24 (2008), 8363–8368.
142. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R., O'Brien, S.J., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter aids cohort study, multicenter hemophilia cohort study, San Francisco City Cohort, ALIVE, Study. Science 273:5283 (1996), 1856–1862.
143. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A., Landau, N.R., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:3 (1996), 367–377.
144. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G., Parmentier, M., Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:6593 (1996), 722–725.
145. Wilkin, T.J., Gulick, R.M., CCR5 antagonism in HIV infection: current concepts and future opportunities. Annu. Rev. Med. 63 (2012), 81–93.
146. Hutter, G., Nowak, D., Mossner, M., Ganepola, S., Mussig, A., Allers, K., Schneider, T., Hofmann, J., Kucherer, C., Blau, O., Blau, I.W., Hofmann, W.K., Thiel, E., Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 360:7 (2009), 692–698.
147. Allers, K., Hutter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., Schneider, T., Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 117:10 (2011), 2791–2799.
148. Kim, M.B., Giesler, K.E., Tahirovic, Y.A., Truax, V.M., Liotta, D.C., Wilson, L.J., CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. Expert Opin. Investig. Drugs 25:12 (2016), 1377–1392.
149. Naranbhai, V., Carrington, M., Host genetic variation and HIV disease: from mapping to mechanism. Immunogenetics 69:8-9 (2017), 489–498.
150. Park, R.J., Wang, T., Koundakjian, D., Hultquist, J.F., Lamothe-Molina, P., Monel, B., Schumann, K., Yu, H., Krupzcak, K.M., Garcia-Beltran, W., Piechocka-Trocha, A., Krogan, N.J., Marson, A., Sabatini, D.M., Lander, E.S., Hacohen, N., Walker, B.D., A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat. Genet. 49:2 (2017), 193–203.
151. Le Pendu, J., Ruvoen-Clouet, N., Kindberg, E., Svensson, L., Mendelian resistance to human norovirus infections. Semin. Immunol. 18:6 (2006), 375–386.
152. Marionneau, S., Cailleau-Thomas, A., Rocher, J., Le Moullac-Vaidye, B., Ruvoen, N., Clement, M., Le Pendu, J., ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83:7 (2001), 565–573.
153. Ferrer-Admetlla, A., Sikora, M., Laayouni, H., Esteve, A., Roubinet, F., Blancher, A., Calafell, F., Bertranpetit, J., Casals, F., A natural history of FUT2 polymorphism in humans. Mol. Biol. Evol. 26:9 (2009), 1993–2003.
154. Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J., Baric, R., Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9:5 (2003), 548–553.
155. Thorven, M., Grahn, A., Hedlund, K.O., Johansson, H., Wahlfrid, C., Larson, G., Svensson, L., A homozygous nonsense mutation (428G–> A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol. 79:24 (2005), 15351–15355.
156. Nordgren, J., Sharma, S., Bucardo, F., Nasir, W., Gunaydin, G., Ouermi, D., Nitiema, L.W., Becker-Dreps, S., Simpore, J., Hammarstrom, L., Larson, G., Svensson, L., Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin. Infect. Dis. 59:11 (2014), 1567–1573.
157. Payne, D.C., Currier, R.L., Staat, M.A., Sahni, L.C., Selvarangan, R., Halasa, N.B., Englund, J.A., Weinberg, G.A., Boom, J.A., Szilagyi, P.G., Klein, E.J., Chappell, J., Harrison, C.J., Davidson, B.S., Mijatovic-Rustempasic, S., Moffatt, M.D., McNeal, M., Wikswo, M., Bowen, M.D., Morrow, A.L., Parashar, U.D., Epidemiologic association between FUT2 secretor status and severe rotavirus gastroenteritis in children in the United States. JAMA Pediatr. 169:11 (2015), 1040–1045.
158. Huang, P., Xia, M., Tan, M., Zhong, W., Wei, C., Wang, L., Morrow, A., Jiang, X., Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J. Virol. 86:9 (2012), 4833–4843.
159. Marionneau, S., Ruvoen, N., Le Moullac-Vaidye, B., Clement, M., Cailleau-Thomas, A., Ruiz-Palacois, G., Huang, P., Jiang, X., Le Pendu, J., Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122:7 (2002), 1967–1977.
160. Kambhampati, A., Payne, D.C., Costantini, V., Lopman, B.A., Host genetic susceptibility to enteric viruses: a systematic review and metaanalysis. Clin. Infect. Dis. 62:1 (2016), 11–18.
161. Garcia de la Cadena, S., Massieu, L., Caspases and their role in inflammation and ischemic neuronal death. Focus on caspase-12. Apoptosis 21:7 (2016), 763–777.
162. Kachapati, K., O'Brien, T.R., Bergeron, J., Zhang, M., Dean, M., Population distribution of the functional caspase-12 allele. Hum. Mutat., 27(9), 2006, 975.
163. Saleh, M., Vaillancourt, J.P., Graham, R.K., Huyck, M., Srinivasula, S.M., Alnemri, E.S., Steinberg, M.H., Nolan, V., Baldwin, C.T., Hotchkiss, R.S., Buchman, T.G., Zehnbauer, B.A., Hayden, M.R., Farrer, L.A., Roy, S., Nicholson, D.W., Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429:6987 (2004), 75–79.
164. Saleh, M., Mathison, J.C., Wolinski, M.K., Bensinger, S.J., Fitzgerald, P., Droin, N., Ulevitch, R.J., Green, D.R., Nicholson, D.W., Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440:7087 (2006), 1064–1068.
165. Xue, Y., Daly, A., Yngvadottir, B., Liu, M., Coop, G., Kim, Y., Sabeti, P., Chen, Y., Stalker, J., Huckle, E., Burton, J., Leonard, S., Rogers, J., Tyler-Smith, C., Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am. J. Hum. Genet. 78:4 (2006), 659–670.
166. Boehm, T., McCurley, N., Sutoh, Y., Schorpp, M., Kasahara, M., Cooper, M.D., VLR-based adaptive immunity. Annu. Rev. Immunol. 30 (2012), 203–220.
167. Cooper, M.D., A life of adventure in immunobiology. Annu. Rev. Immunol. 28 (2010), 1–19.
168. Rieux-Laucat, F., Casanova, J.L., Immunology autoimmunity by haploinsufficiency. Science 345:6204 (2014), 1560–1561.